Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NTpharma logo — Delivering next-generation nanovaccines and biopharmaceutica...

NTpharma

Delivering next-generation nanovaccines and biopharmaceuticals faster for global health protection.

Founded 2011 Series Unknown Biopharma, Biotechnology +2

General Information

Company Name NTpharma
Founded Year 2011
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series Unknown
Social

Get notified when NTpharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NTpharma

NTpharma is a pioneering biopharmaceutical company founded in 2011. Specializing in the GMP production of nanovaccines and biopharmaceuticals with carbohydrate binders, the company's slogan "Delivering next-generation nanovaccines and biopharmaceuticals faster for global health protection" encapsulates its mission. NTpharma has received a Venture Round investment from RUSNANO on 28 July 2009. The company is focused on constructing a state-of-the-art facility in Pereslavl’-Zalessky, approximately 150 kilometers northeast of Moscow, dedicated to the manufacturing of vaccines and pharmaceuticals. Their efforts are geared towards producing next-generation vaccines, including a polyvalent human flu vaccine, and developing pharmaceuticals for detoxification in oncological therapy and treatment of amyotrophic lateral sclerosis (ALS/Lou Gehrig’s disease). NTpharma's groundbreaking technology has significantly reduced the time needed for culturing and producing vaccines, providing a crucial advantage in addressing rapidly spreading pandemic flu strains. The company operates within the realms of Biopharma, Biotechnology, Health Care, and Manufacturing.

Taxonomy: biopharmaceuticals, nanovaccines, GMP production, carbohydrate binders, vaccine manufacturing, pharmaceutical production, polyvalent human flu vaccine, oncological therapy, ALS treatment, innovative technology, R&D, global health, pandemic flu, production facility, Pereslavl’-Zalessky

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 28 Jul 2009

NTpharma Alternatives & Competitors

NTpharma vs
TechnoVax, Inc.
TechnoVax, Inc. United States

TechnoVax is a privately held near-clinical-stage biotechnology company based in Tarrytown, NY speci...

Equity Crowdfunding
5 employees
Health Care
NTpharma vs
VaxInnate
VaxInnate

Advancing the future of healthcare with innovative vaccines for flu, malaria, dengue, papillomavirus...

Series Unknown
Biotechnology, Health Care
NTpharma vs
IMUTEX Ltd
IMUTEX Ltd

A joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the development...

Seed
2 employees
Biotechnology, Health Care

FAQ About NTpharma

Delivering next-generation nanovaccines and biopharmaceuticals faster for global health protection.
NTpharma was founded in 2011.
NTpharma operates in the following industries: Biopharma, Biotechnology, Health Care, Manufacturing.
NTpharma has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to NTpharma include TechnoVax, Inc., VaxInnate, IMUTEX Ltd, Nanopass Technologies Ltd., Biological E. Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NTpharma and TechnoVax, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NTpharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy